Continuous vs thrice-daily ceftazidime for elective intravenous antipseudomonal therapy in cystic fibrosis.
Riethmueller J, Junge S, Schroeter TW, Kuemmerer K, Franke P, Ballmann M, Claass A, Broemme S, Jeschke R, Hebestreit A, Staab D, Koetz K, Doering G, Stern M.
Riethmueller J, et al. Among authors: jeschke r.
Infection. 2009 Oct;37(5):418-23. doi: 10.1007/s15010-009-8116-5. Epub 2009 Sep 5.
Infection. 2009.
PMID: 19756419
Clinical Trial.